Removing all visible cancer is key to treating aggressive brain tumors

September 15, 2015
Removing all visible cancer is key to treating aggressive brain tumors
Study of almost 100 children also finds greater survival rate for girls than boys after surgery.

(HealthDay)—Surgery that removes all visible cancer significantly improves the chances of survival for children with aggressive brain tumors, especially girls.

That's the finding of a study that included almost 100 children treated for high-grade glioma between 1988 and 2010. These rare brain tumors occur in fewer than one in 100,000 children and teens.

After two years, the overall survival rate was 45 percent; 25 percent had no cancer progression.

Surgery to remove all visible signs of cancer was successful in one-third of the children. Their median survival was 3.4 years, compared with 1.6 years for those who did not have all visible cancer removed. Median means half of the children lived longer, half did not.

The after successful surgery was much greater in girls, with median survival of 8.1 years. Boys had a median survival of 2.4 years.

The study is published in the September issue of the journal Neurosurgery.

Surgical removal of all visible cancer is already the standard of care, but this study reinforces its importance in improving survival, according to Dr. Jeffrey Greenfield and colleagues. Greenfield is an associate professor of neurological surgery at Weill Cornell Medical College in New York City.

High-grade gliomas account for 8 percent to 12 percent of brain tumors in children, and about 30 percent of in adults.

Explore further: Complete resection of high-grade brain cancer yields better survival in children—especially girls

More information: The U.S. National Library of Medicine has more about childhood brain tumors.

Related Stories

Complete resection of high-grade brain cancer yields better survival in children—especially girls

August 18, 2015
For children with aggressive brain cancers called high-grade gliomas (HGG), the chances of survival are improved when surgery is successful in eliminating all visible cancer, reports a study in the September issue of Neurosurgery, ...

Gender influences survival after pediatric brain tumor removal

August 26, 2015
It's an unexpected discovery: All else being equal, girls whose rare and deadly brain tumors are fully removed live almost six years longer than boys with the same condition.

Improved survival in adult patients with low-grade brain tumors

July 1, 2015
Using clinical data collected over the past decade through a U.S. cancer registry, researchers at the University of California, San Diego School of Medicine demonstrated that significant strides have been made in improving ...

Laparoscopic surgery achieves similar survival rates in rectal cancer

April 2, 2015
(HealthDay)—Patients with localized rectal cancer may achieve similar survival rates by having minimally invasive laparoscopic surgery, instead of more invasive open surgery, according to new research published in the April ...

Clinical trial suggests combination therapy is best for low-grade brain tumors

March 10, 2015
New clinical-trial findings provide further evidence that combining chemotherapy with radiation therapy is the best treatment for people with a low-grade form of brain cancer. The findings come from a phase II study co-led ...

When cancer makes its way to the brain

August 27, 2015
Only half of brain cancers actually start in the brain. The rest—as in the case of former President Jimmy Carter—are metastatic tumors from cancer that originated elsewhere in the body.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.